ERGO.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 lapkr. 2023 @ 18:29):

Stats
Šios dienos apimtis	33 234.00
Vidutinė apimtis	922 955
Rinkos kapitalizacija	771.71M
EPS	£0 ( 2024-03-18 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	48.14
ATR14	£15.31 (1.14%)

Tūris Koreliacija

Ilgas: 0.36 (neutral)

Trumpas: 0.07 (neutral)

Signal:(66.053) Neutral

Ergomed PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Ergomed PLC Koreliacija - Valiuta/Žaliavos

-0.75
( moderate negative )

-0.77
( moderate negative )

0.56
( weak )

-0.71
( moderate negative )

0.01
( neutral )

0.78
( moderate )

Ergomed PLC Finansinės ataskaitos

Annual	2022
Pajamos:	£145.26M
Bruto pelnas:	£59.15M (40.72 %)
EPS:	£0.300

FY	2022
Pajamos:	£145.26M
Bruto pelnas:	£59.15M (40.72 %)
EPS:	£0.300

FY	2021
Pajamos:	£118.58M
Bruto pelnas:	£48.36M (40.78 %)
EPS:	£0.260

FY	2020
Pajamos:	£86.39M
Bruto pelnas:	£39.65M (45.90 %)
EPS:	£0.200

Financial Reports:

No articles found.

Ergomed PLC

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.